Get started
Work

Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research

Year: 2022
Type: article
DOI: 10.1016/s2213-2600(22)00182-5
Authors: Neal L Benowitz, Maciej L Goniewicz, Bonnie Halpern-Felsher, Suchitra Krishnan-Sarin, Pamela M Ling, Richard J O'Connor, Mary Ann Pentz, Rose Marie Robertson, Aruni Bhatnagar
Institutions: University of California, San Francisco, Roswell Park Comprehensive Cancer Center, Stanford Medicine, Stanford University, Yale University, University of Southern California, Vanderbilt University Medical Center, University of Louisville
Language: English
Field: Medicine
Open Access status: bronze
Funders: American Heart Association, Tobacco-Related Disease Research Program, Yale University, Stanford University, National Institutes of Health, U.S. Food and Drug Administration, University of California, San Francisco, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Cancer Institute, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences
Awards: G1044130170, G1789321906, Clinical Pharmacology of Electronic Cigarettes, American Heart Association Tobacco Regulation and Addiction Center (A-TRAC), G2459635008, G3048856645, G3070111569, G3580900822, G4150508603, Understanding Smokeless Tobacco and Electronic Cigarette Marketing, G6694471877, G7332903808, G7440272120, University of Louisville Center for Integrative Environmental Health Sciences, USC Tobacco Center of Regulatory Science (TCORS) for Vulnerable Populations, G882415787, G9000006607, G9000089987, G9000091002, G9000156370, G9000231881, G9000245010, G9000291477, G9000331002, Yale Clinical and Translational Science Award, American Heart Association Tobacco Center for Regulatory Science (A-TRAC) 2.0
OpenAlex ID: W4292675877
FWCI: 7.574
Cites: 192
Cited by: 71
Related to: 10